Sample size
The sample size was calculated by a statistician at the Biostatistics Center, Kurume University, and an enrollment of at least 300 patients for each disease (asthma and COPD) was needed for investigations of pharmacological adherence to medicines as demonstrated by previous studies [1, 2] . The beta error (power) and alpha error were statistically set as 0.20 (80%) and 0.05, respectively. We set a deadline for enrollment of patients (July 31 
Supplementary Table 3. Comorbid diseases
Notes: Patients with asthma-COPD overlap and other respiratory diseases were excluded in the study. Among comorbid diseases, patients with asthma had a significantly higher percentage of patients with rhinosinusitis, and also had a lower percentage of patients with any heart diseases (heart failure, arrhythmia and coronary diseases) and benign prostate hyperplasia compared to COPD patients. However, none had pulmonary hypertension, liver cirrhosis, renal failure with dialysis, and human immunodeficiency virus infection as comorbid diseases. Four patients had history of inactive malignancies. Three patients with breast cancer and one patient with prostatic cancer were controlled with maintenance hormonal therapy in patients with asthma, whereas none had malignancies in patients with COPD. 
Abbreviations: COPD, chronic obstructive pulmonary disease

